# Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

Study · id `cardio:ct-nct05105633` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05105633](<https://clinicaltrials.gov/study/NCT05105633>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05105633

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 688 participants.

## Technical summary

Registry record NCT05105633. Randomized; no masking; primary purpose treatment. Start 2021-11-29 (actual); primary completion 2028-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 688 participants (planned count; ClinicalTrials.gov record NCT05105633, source copy `cardio:ctgov-nct05105633-2026-05-06`, retrieved 2026-10-26)
- Started: 2021-11-29 (actual) (ClinicalTrials.gov record NCT05105633, source copy `cardio:ctgov-nct05105633-2026-05-06`, retrieved 2026-10-26)
- Primary completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT05105633, source copy `cardio:ctgov-nct05105633-2026-05-06`, retrieved 2026-10-26)
- Completion: 2029-05 (anticipated) (ClinicalTrials.gov record NCT05105633, source copy `cardio:ctgov-nct05105633-2026-05-06`, retrieved 2026-10-26)
- Countries: Australia; Brazil; France (ClinicalTrials.gov record NCT05105633, source copy `cardio:ctgov-nct05105633-2026-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05105633-2026-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
- Acronym: POST-ETERNAL
- Condition: Basilar Artery Occlusion
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Standard Care (which may include intravenous Alteplase)
- Lead sponsor: University of Melbourne
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: University of Melbourne (`cardio:org-university-of-melbourne`)

## Provenance

Content hash: b308fb0a875b3d1b18dafb3ba31b2df4be38db370db721b8df713224b55ae055
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
